Flair Health
Flair Health, founded in 2023, offers a technology-enabled platform designed to optimize financial workflows for specialty medication billing. The platform helps pharmacies, clinics, and infusion centers maximize reimbursements by accelerating claims processes and unlocking alternative payment sources. Flair's proprietary AI tool automates follow-ups on overdue or denied claims, ensuring accurate tracking of patient accounts and payments. With a focus on improving patient access to medications, Flair Health integrates seamlessly with existing systems, reducing administrative burdens for pharmacy teams and patient coordinators. The company is positioned to enhance revenue recovery and improve cash flow in the specialty pharmacy sector.
Flair Health
Flair Health, founded in 2023, offers a technology-enabled platform designed to optimize financial workflows for specialty medication billing. The platform helps pharmacies, clinics, and infusion centers maximize reimbursements by accelerating claims processes and unlocking alternative payment sources. Flair's proprietary AI tool automates follow-ups on overdue or denied claims, ensuring accurate tracking of patient accounts and payments. With a focus on improving patient access to medications, Flair Health integrates seamlessly with existing systems, reducing administrative burdens for pharmacy teams and patient coordinators. The company is positioned to enhance revenue recovery and improve cash flow in the specialty pharmacy sector.
TL;DR
Founded: 2023
Headquarters: San Francisco, California, United States
Product focus: Technology-enabled platform to optimize specialty medication billing and accelerate claims
Founders / Leadership: Diva Sharma (CEO, Co‑Founder); Shobha Dasari (Co‑Founder, CTO)
Notable investor: Y Combinator
Company Overview
Problem Domain
Specialty pharmacy billing, claims processing, revenue recovery, patient access to medications
Founded
2023
Industry
Healthcare technology
Funding Track Record
125000.00
Early-stage financing associated with Y Combinator participation (YC S23); public sources show a Sep 2023 seed entry listing $125k.
Investor Signal
“Y Combinator as investor/lead”